Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging. - Wikidata - wikimedia - TriplyDB

Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging.

Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging.

http://www.wikidata.org/entity/Q36600399

about

Entorhinal Cortex Thickness across the Human Lifespan Delineation of hippocampal subregions using T1-weighted magnetic resonance images at 3 Tesla.Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2 Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum.Improved DTI registration allows voxel-based analysis that outperforms tract-based spatial statistics.Blood-brain barrier breakdown in the aging human hippocampus Power estimation for non-standardized multisite studies Florbetapir positron emission tomography and cerebrospinal fluid biomarkers.The New Criteria for Alzheimer's Disease - Implications for Geriatricians Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease.Alzheimer's disease severity, objectively determined and measured.The interactive effect of demographic and clinical factors on hippocampal volume: A multicohort study on 1958 cognitively normal individuals.Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment."New Old Pathologies": AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS).A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment.Supporting evidence for using biomarkers in the diagnosis of MCI due to AD.Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients.The development of a stochastic mathematical model of Alzheimer's disease to help improve the design of clinical trials of potential treatments.Impact of Recruitment Methods in Subjective Cognitive Decline.Treatment of Mild Cognitive Impairment.

P2860

Q30278092-8AECBD55-90D5-4863-90D3-076F7FB2FFF2 Q30370858-4B2F3BEA-4F3C-43A0-ACD6-99D593DFF89C Q30577777-FBEE7AE9-330D-433F-B8D3-2F1B21755690 Q30971403-5D3D38CC-9CA1-4C85-BACE-167B67FE4B52 Q30981669-905F9168-B0FD-4CCE-B8D2-E9971FCA1DE3 Q34047125-D70BC679-0E9C-4B88-A52F-88560D3491BA Q34064379-1DC0D688-809C-4291-AD94-FE98C4A78F32 Q35151019-E4E675DD-E347-4896-8690-D741F0943E76 Q35978198-F96ADADE-1CA2-4E29-9B5C-17D5593172F3 Q35981544-AAF2E157-63BC-4C3F-8F8F-427EC716D83D Q37041385-C8C23DB1-B4B6-4FCE-BF42-04BB07AAB127 Q37184248-A7921834-12F6-484B-9387-6463FF744A10 Q37363931-76B5D14F-A837-4351-B741-4F548A0B8FB6 Q38732582-37D08A34-9B0B-463E-A5F9-E6210339AD1F Q38773523-46A6BCC3-7662-4338-A8A1-7CA92699549C Q38841003-38C9B4B6-AACC-4436-94F8-0FA894059D1F Q40101067-D47B132D-2983-47ED-AEAB-A4EC45CEE422 Q44780014-A5006C05-5652-4475-BC80-742090C2B460 Q45178246-5090A0EA-F5FD-4883-BF6D-CD16B080FDC6 Q47134237-9EEC95DB-50D2-4AE4-8EA0-448124DA2B6A Q47555369-60453AE8-B391-4AAA-B21C-BCA30989AC5C Q47952621-60B3CC07-4B07-496A-A9A9-B581B1A1AFD8 Q50720439-8DE7433D-1FBC-4D28-8C13-854C9BC66249

P2860

Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging.

http://www.wikidata.org/entity/Q36600399

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Comparison of imaging biomarke ...... he Mayo Clinic Study of Aging.

@ast

Comparison of imaging biomarke ...... he Mayo Clinic Study of Aging.

@en

type

label

Comparison of imaging biomarke ...... he Mayo Clinic Study of Aging.

@ast

Comparison of imaging biomarke ...... he Mayo Clinic Study of Aging.

@en

prefLabel

Comparison of imaging biomarke ...... he Mayo Clinic Study of Aging.

@ast

Comparison of imaging biomarke ...... he Mayo Clinic Study of Aging.

@en

P1433

Q36600399-02F13677-6600-42A2-96E8-BA2A20BD6783

P1476

Q36600399-CCD75C53-5D47-402F-9CD8-8FA0E64DCB80

P2093

Q36600399-0C499BCF-B6B0-44E9-B4E8-CA24653699ED

Q36600399-1402D405-D397-4B43-BE5C-DCA0411B945D

Q36600399-1BDF6E4F-FEB2-4881-ADA1-E9920C6574F0

Q36600399-93B2B65B-828D-42D1-951C-9690282C3851

Q36600399-D895AD8A-DCB2-4376-BCAA-80ABD7A311DA

Q36600399-F94F06EF-80F8-489B-8747-82BDF72C3798

Q36600399-FBF8E0BD-6463-42D7-8070-E8C8EA7FFE90

P2860

Q36600399-01BB2B51-D5FA-46CA-A47B-E69444636187

Q36600399-03606EFE-FEFC-4D6F-AD06-D018DA1D60B7

Q36600399-07A78EAD-492C-45BE-8495-3F12BC2CE1EE

Q36600399-087F23C8-19FD-4997-853B-ABF7458BD1F5

Q36600399-0EB9C735-900D-4A68-B487-0E65ABCC7CB4

Q36600399-16958277-5F1B-42B2-9036-2F6DBC1AE52B

Q36600399-1B1142D3-98C1-407A-8F31-DF9A25F5F426

Q36600399-1C06AF14-BD8C-43F8-A6AE-83BCA02797E0

Q36600399-1CC67D68-A1DE-4211-9753-B24CD1AA14D4

Q36600399-1FA36B86-4BA3-44FF-A9D0-C90F033784FA

P304

Q36600399-7306B29A-54C8-4963-99CC-D8EB67665092

P31

Q36600399-50FBFE6F-F05C-4E3A-BB36-8F28462056A8

P356

Q36600399-2714C589-038E-46CC-B275-E40544C18F9C

P433

Q36600399-157B0F0B-D739-422B-9A3B-970CF715D5C6

P478

Q36600399-A980D39C-6B30-4072-9A17-8546C38F1F11

P50

Q36600399-4AFF14AE-68F8-49E1-9B94-5277C5DC7697

Q36600399-9CF88C97-CE52-4267-A8CC-121850488EAB

Q36600399-C5E99C1C-0334-429A-9BEC-CED7906154DD

P577

Q36600399-F292527A-3F64-4E1C-AB0C-5D7BC234FF0C

P5875

Q36600399-62496898-424C-4EE7-83A2-FEC796264B48

P698

Q36600399-61FD09A4-E61D-46D7-880B-04CB4D0DD7CF

P921

Q36600399-260B3B0E-F7EE-4504-8A25-4746E1326FF2

Q36600399-339C8A82-2C83-4385-A167-B6078D77DBC9

Q36600399-F4B80689-9FE6-406A-A32E-3CB58A091E91

P932

Q36600399-BC04653F-20FB-45CE-9F87-98DC6EBAE9EC

P356

ARCHNEUROL.2011.3029

P1433

P1476

Comparison of imaging biomarke ...... he Mayo Clinic Study of Aging.

@en

P2093

Alzheimer Disease Neuroimaging Initiative

http://www.w3.org/2001/XMLSchema#string

Bradley F Boeve

http://www.w3.org/2001/XMLSchema#string

Heather J Wiste

http://www.w3.org/2001/XMLSchema#string

Jennifer L Whitwell

http://www.w3.org/2001/XMLSchema#string

Rosebud O Roberts

http://www.w3.org/2001/XMLSchema#string

Stephen D Weigand

http://www.w3.org/2001/XMLSchema#string

Walter A Rocca

http://www.w3.org/2001/XMLSchema#string

P2860

Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.

MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

“Mini-mental state”

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain

The Clinical Dementia Rating (CDR): current version and scoring rules

Mild cognitive impairment as a diagnostic entity

Atrophy rates accelerate in amnestic mild cognitive impairment.

Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data.

P304

614-622

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUROL.2011.3029

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Ronald C. Petersen

David S Knopman

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229065135

http://www.w3.org/2001/XMLSchema#string

P698

22782510

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's Disease Neuroimaging Initiative

P932

3569033

http://www.w3.org/2001/XMLSchema#string